期刊文献+

丙泊酚联合雷米芬太尼在臂丛神经阻滞中的麻醉效果分析 被引量:7

Analysis of Anesthesia Effects of Propofol Combined with Remifentanil in Brachial Plexus Block
下载PDF
导出
摘要 目的研究分析丙泊酚联合雷米芬太尼在臂丛神经阻滞中的麻醉效果。方法选取保定市第五医院于2011年1月至2012年2月收治的64例实行臂丛神经阻滞麻醉患者,随机分为观察组和对照组,每组各32例。患者在成功麻醉之后,对照组使用丙泊酚静脉注射来维持麻醉效果;观察组使用丙泊酚和雷米芬太尼来维持麻醉效果。对比两组患者的镇静效果以及疼痛程度,并比较各时间点的心率、呼吸率、血氧饱和度、舒张压、收缩压。结果观察组的镇静、镇痛效果显著优于对照组(P<0.05);观察组与对照组各时间点的心率、呼吸率、血氧饱和度比较差异有统计学意义(P<0.05);两组的舒张压与收缩压比较差异无统计学意义(P>0.05)。结论丙泊酚联合雷米芬太尼在臂丛神经阻滞中的麻醉效果良好,具有良好的镇静和镇痛作用,保持血流动力学的各项指标稳定,安全有效,值得推广。 Objective To study the anesthesia effect of propofol combined remifentanil in brachial plex- us block. Methods In the Fifth Hospital of Baoding City from Jan. 2011 to Feb. 2012, clinical data of 64 cases with brachial plexus nerve block anesthesia was selected, the patients were randomly divided into obser- vation group and control group, each group of 32 cases. After successful anesthesia in the control group, propofol intravenous anesthesia was used to maintain. The observation group used propofo| and remifentanil for maintenance, sedation effec and pain degree, and HR, RR, SpO2 , DBP, SBP at different time points of the two groups were compared. Results The sedation effect and analgesia of the observation group was signifi- cantly better than the control group ( P 〈 0.05 ). There was statistically significant difference between the observation group and the control group in FIR, RR, SpO2 ( P 〈 0.05 ) at each time point, no significant differ- ence was observed in DBP and SBP( P 〉 0.05). Conclusion The effect of propofol combined with remifen- tanil anesthesia in brachial plexus block is good, with good sedation and analgesia effect, stably maintained hemodynamic indexes, safe and effective,which is worthy of promotion.
作者 孙卫宇
出处 《医学综述》 2013年第22期4211-4213,共3页 Medical Recapitulate
关键词 丙泊酚 雷米芬太尼 臂丛神经阻滞麻醉 效果 Propofol Remifentanil Brachial plexus block anesthesia Effect
  • 相关文献

参考文献8

二级参考文献34

  • 1高萍.靶控输注丙泊酚复合氯胺酮在小儿非插管全麻中的应用[J].哈尔滨医药,2005,25(4):13-14. 被引量:1
  • 2Ronald D.Miller.主编,曾因明,邓小明,主译.米勒麻醉学[M].第6版.北京:北京大学出版社,2006,473-474.
  • 32,Stiller RL, Davis PJ, McGowan FX, et al. In vitro metabo-
  • 43,James MK.Remifentanil and anesthesia for the future.Experimental Opinion in Investigational Drugs,1994,3∶331.
  • 54,Egan TD.Remifentanil pharmacokinetics and pharmacodynamics.A preliminary appraisal.Clinical Pharmacokinetics,1995,29∶80.
  • 65,Hughes MA,Glass PSA,Jacobs JR.Context sensitive half-tine in multicompartment for intravenous anesthetic drugs.Anesthesiology,1992,76∶334.
  • 76,Dershwitz M,Rosow CE,Michalowski P,et al.Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease compared with normal subjects.Anesthesiology,1994,81∶A377.
  • 87,Hoke J, Muir K, Glass P, et al. Pharmacokinetics of remifentanil and its metabolite(GI90291)in subjects with renal diseases.Clin Ptharmacol Ther, 1995,57∶148.
  • 98,Schuttler J,Albreght S,Breivik H,et al.A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery.Anaesthesia,1997,52∶307.
  • 109,Hogue CW jr,Bowdle TA,O′Leary C,et al.A multicenter evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatient surgery.Anesth Analg,1996,83∶279.

共引文献265

同被引文献33

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部